News for Trean Insurance Group, Inc. (TIG)

AM Best has affirmed the Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb” (Good) of Trean Insurance Group, Inc (Trean). The outlook of the Credit Rating is stable.

Trean Insurance Group, a provider of products and services to the specialty insurance market, has been acquired by Altaris, collectively with its

WAYZATA, Minn. and NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Trean Insurance Group, Inc. (“Trean” or the “Company”), a leading provider of products...

Transaction Anticipated to Close in April 2023...

NEW YORK, April 12, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

/PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Trean Insurance Group, Inc....

NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.85%

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 400 points on Friday.

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday.

Read Equities Research Analysts’ Upgrades for June 8th (AIBRF, BTGOF, CFRX, CPG, CRARY, ERF, EVGO, GWW, HXPLF, JKS) at ETF Daily News

Read Equities Research Analysts’ Upgrades for May 27th (AAWW, AN, ATDRY, ATO, AUTO, BOOT, BSX, DML, DNN, DXC) at ETF Daily News

During Thursday, 166 stocks hit new 52-week lows. 52-Week Low Highlights: Alibaba Group Holding (NYSE:BABA) was the largest firm on a market cap ...